The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Shigehiro Tsukahara
No Relationships to Disclose
 
Shugo Yajima
No Relationships to Disclose
 
Masaki Shiota
Honoraria - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Chugai Pharma; Janssen; Sanofi; Takeda
Research Funding - Astellas Pharma
 
Takahiro Osawa
Honoraria - Eisai; Merck; MSD; Ono Pharmaceutical; Takeda
 
Takahiro Kojima
No Relationships to Disclose
 
Taigo Kato
Honoraria - Bristol-Myers Squibb Japan; Merck; MSD; Pfizer; Takeda
Research Funding - Takeda
 
Nobuyuki Tanaka
No Relationships to Disclose
 
Yujiro Hayashi
No Relationships to Disclose
 
Hitoshi Masuda
No Relationships to Disclose
 
Takashige Abe
No Relationships to Disclose
 
Mototsugu Oya
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; Janssen; Merck; MSD; Novartis; Pfizer; Takeda
 
Masashi Nakayama
Honoraria - Astellas Pharma; AstraZeneca Japan; Bayer Yakuhin; Bristol Myers Squibb; Chugai Pharma; Eisai; Janssen; Kissei Pharmaceutical; Merck; Merck; Ono Pharmaceutical; Sanofi; Takeda
 
Greg Hogan
Employment - Myriad Genetics
Travel, Accommodations, Expenses - Myriad Genetics
 
Metin Balaban
Employment - Myriad Genetics
Travel, Accommodations, Expenses - Myriad Genetics
 
Jeff Jasper
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Travel, Accommodations, Expenses - Myriad Genetics
 
Tadayoshi Hashimoto
Honoraria - Cytogen; Takata Pharmaceutical
 
Eiji Oki
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Guardant Health
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Merck; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Indivumed; Sumitomo Corp.
Research Funding - Bristol-Myers Squibb Japan (Inst); Caris MPI (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Eisai (Inst); Exact Sciences (Inst); FALCO biosystems Ltd. (Inst); Medical & Biological Laboratories Co., Ltd. (Inst); Merus (Inst); Miyarisan pharmaceutical (Inst); MSD (Inst); Natera (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Norio Nonomura
Honoraria - Astellas Pharma; AstraZeneca; Asuka Seiyaku; Bayer; Bristol-Myers Squibb; Chugai Pharma; Eisai; Janssen; Kissei Pharmaceutical; Kyorin; MSD; Nippon Shinyaku; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Nippon Shinyaku (Inst)
 
Masatoshi Eto
Consulting or Advisory Role - Boston Scientific; Chugai Pharma; Eisai; Ferring; Intuitive Surgical; Merck; MSD; Novartis; Pfizer; Takeda
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck; MSD; ONO PHARMACEUTICAL; Pfizer; Takeda
Research Funding - MSD